Evidence map›Paper›PMID 37762568›Full record

ArticleInternational journal of molecular sciences2023

High Recovery Chromatographic Purification of mRNA at Room Temperature and Neutral pH.

Rok Miklavčič, Polona Megušar, Špela Meta Kodermac, Blaž Bakalar, Darko Dolenc, Rok Sekirnik, Aleš Štrancar, Urh Černigoj

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rok MiklavčičSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.
Polona MegušarSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.
Špela Meta KodermacSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.
Blaž BakalarSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.
Darko DolencSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.
Rok SekirnikSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.ORCID 0000-0001-6008-9500
Aleš ŠtrancarSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.
Urh ČernigojSartorius BIA Separations d.o.o., Mirce 21, 5270 Ajdovščina, Slovenia.ORCID 0000-0001-9397-0759

Funding

European Innovation Council 101047214
6 · The paper itself

Abstract

Messenger RNA (mRNA) is becoming an increasingly important therapeutic modality due to its potential for fast development and platform production. New emerging RNA modalities, such as circular RNA, drive the need for the development of non-affinity purification approaches. Recently, the highly efficient chromatographic purification of mRNA was demonstrated with multimodal monolithic chromatography media (CIM

Indexed as

ChromatographyHydrogen-Ion ConcentrationPlasmidsRNA, MessengerTemperatureRNA, Messengerchromatographic monolithsisoelectric pointliquid chromatographymRNA stabilitynucleic acids separationplatform purificationpreparative chromatographyweak anion-exchanger

Identifiers

PMID37762568
PMCPMC10532270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.